Proneural-mesenchymal antagonism dominates the patterns of phenotypic heterogeneity in glioblastoma

Summary: The aggressive nature of glioblastoma (GBM) – one of the deadliest forms of brain tumors – is majorly attributed to underlying phenotypic heterogeneity. Early attempts to classify this heterogeneity at a transcriptomic level in TCGA GBM cohort proposed the existence of four distinct molecul...

Full description

Bibliographic Details
Main Authors: Harshavardhan BV, Mohit Kumar Jolly
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S258900422400405X
_version_ 1797295722206330880
author Harshavardhan BV
Mohit Kumar Jolly
author_facet Harshavardhan BV
Mohit Kumar Jolly
author_sort Harshavardhan BV
collection DOAJ
description Summary: The aggressive nature of glioblastoma (GBM) – one of the deadliest forms of brain tumors – is majorly attributed to underlying phenotypic heterogeneity. Early attempts to classify this heterogeneity at a transcriptomic level in TCGA GBM cohort proposed the existence of four distinct molecular subtypes: Proneural, Neural, Classical, and Mesenchymal. Further, a single-cell RNA sequencing (scRNA-seq) analysis of primary tumors also reported similar four subtypes mimicking neurodevelopmental lineages. However, it remains unclear whether these four subtypes identified via bulk and single-cell transcriptomics are mutually exclusive or not. Here, we perform pairwise correlations among individual genes and gene signatures corresponding to these proposed subtypes and show that the subtypes are not distinctly mutually antagonistic in either TCGA or scRNA-seq data. We observed that the proneural (or neural progenitor-like)-mesenchymal axis is the most prominent antagonistic pair, with the other two subtypes lying on this spectrum. These results are reinforced through a meta-analysis of over 100 single-cell and bulk transcriptomic datasets as well as in terms of functional association with metabolic switching, cell cycle, and immune evasion pathways. Finally, this proneural-mesenchymal antagonistic trend percolates to the association of relevant transcription factors with patient survival. These results suggest rethinking GBM phenotypic characterization for more effective therapeutic targeting efforts.
first_indexed 2024-03-07T21:53:02Z
format Article
id doaj.art-2510ffd140774162b08ae59d8e6231c6
institution Directory Open Access Journal
issn 2589-0042
language English
last_indexed 2024-03-07T21:53:02Z
publishDate 2024-03-01
publisher Elsevier
record_format Article
series iScience
spelling doaj.art-2510ffd140774162b08ae59d8e6231c62024-02-25T04:36:17ZengElsevieriScience2589-00422024-03-01273109184Proneural-mesenchymal antagonism dominates the patterns of phenotypic heterogeneity in glioblastomaHarshavardhan BV0Mohit Kumar Jolly1IISc Mathematics Initiative, Indian Institute of Science, Bengaluru, Karnataka 560012, IndiaDepartment of Bioengineering, Indian Institute of Science, Bengaluru, Karnataka 560012, India; Corresponding authorSummary: The aggressive nature of glioblastoma (GBM) – one of the deadliest forms of brain tumors – is majorly attributed to underlying phenotypic heterogeneity. Early attempts to classify this heterogeneity at a transcriptomic level in TCGA GBM cohort proposed the existence of four distinct molecular subtypes: Proneural, Neural, Classical, and Mesenchymal. Further, a single-cell RNA sequencing (scRNA-seq) analysis of primary tumors also reported similar four subtypes mimicking neurodevelopmental lineages. However, it remains unclear whether these four subtypes identified via bulk and single-cell transcriptomics are mutually exclusive or not. Here, we perform pairwise correlations among individual genes and gene signatures corresponding to these proposed subtypes and show that the subtypes are not distinctly mutually antagonistic in either TCGA or scRNA-seq data. We observed that the proneural (or neural progenitor-like)-mesenchymal axis is the most prominent antagonistic pair, with the other two subtypes lying on this spectrum. These results are reinforced through a meta-analysis of over 100 single-cell and bulk transcriptomic datasets as well as in terms of functional association with metabolic switching, cell cycle, and immune evasion pathways. Finally, this proneural-mesenchymal antagonistic trend percolates to the association of relevant transcription factors with patient survival. These results suggest rethinking GBM phenotypic characterization for more effective therapeutic targeting efforts.http://www.sciencedirect.com/science/article/pii/S258900422400405XMathematical biosciencesExpression studyCancerTranscriptomics
spellingShingle Harshavardhan BV
Mohit Kumar Jolly
Proneural-mesenchymal antagonism dominates the patterns of phenotypic heterogeneity in glioblastoma
iScience
Mathematical biosciences
Expression study
Cancer
Transcriptomics
title Proneural-mesenchymal antagonism dominates the patterns of phenotypic heterogeneity in glioblastoma
title_full Proneural-mesenchymal antagonism dominates the patterns of phenotypic heterogeneity in glioblastoma
title_fullStr Proneural-mesenchymal antagonism dominates the patterns of phenotypic heterogeneity in glioblastoma
title_full_unstemmed Proneural-mesenchymal antagonism dominates the patterns of phenotypic heterogeneity in glioblastoma
title_short Proneural-mesenchymal antagonism dominates the patterns of phenotypic heterogeneity in glioblastoma
title_sort proneural mesenchymal antagonism dominates the patterns of phenotypic heterogeneity in glioblastoma
topic Mathematical biosciences
Expression study
Cancer
Transcriptomics
url http://www.sciencedirect.com/science/article/pii/S258900422400405X
work_keys_str_mv AT harshavardhanbv proneuralmesenchymalantagonismdominatesthepatternsofphenotypicheterogeneityinglioblastoma
AT mohitkumarjolly proneuralmesenchymalantagonismdominatesthepatternsofphenotypicheterogeneityinglioblastoma